← LyondellBasell Industries N.V.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $29.2b | $34.5b | $38.1b | $33.9b | $27.0b | $45.1b | $49.4b | $41.1b | $40.3b | $30.2b | |
| Cost of Goods and Services Sold | $23.2b | $28.1b | $32.5b | $29.3b | $24.4b | $37.4b | $43.8b | $35.8b | $35.7b | $27.6b | |
| Cost of sales | $23.2b | $28.1b | $32.5b | $29.3b | $24.4b | $37.4b | $43.8b | $35.8b | $35.7b | $27.6b | |
| Gross Profit (Calculated) | $6.0b | $6.4b | $5.6b | $4.6b | $2.6b | $7.7b | $5.6b | $5.3b | $4.6b | $2.6b | |
| Operating costs and expenses | $24.1b | $29.0b | $33.8b | $30.6b | $26.2b | $39.4b | $45.4b | $38.1b | $38.5b | $30.6b | |
| Operating Income (Loss) | $5.1b | $5.5b | $5.2b | $4.1b | $1.6b | $6.8b | $5.1b | $3.1b | $1.8b | ($420.0m) | |
| Additional Financial Items | |||||||||||
| Dividends on redeemable non-controlling interests | — | — | ($2) | ($7) | ($7) | ($7) | ($7) | ($7) | ($7) | ($7) | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | $5.0m | — | — | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($4.0m) | ($1.0m) | $24.0m | $9.0m | ($7.0m) | ($2.0m) | ($14.0m) | ($34.0m) | $15.0m | $6.0m | |
| Gain (loss) on sale of business | — | — | — | — | — | — | $0 | $0 | $284.0m | ($6.0m) | |
| Goodwill impairments | — | — | — | — | — | — | — | $252.0m | $0 | $972.0m | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | — | $252.0m | — | $972.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $2.5b | $2.4b | $2.8b | $1.6b | ($456.0m) | $3.5b | $3.3b | $2.0b | $1.7b | ($219.0m) | |
| Income (Loss) from Continuing Operations, Per Basic Share | $9 | $12 | $12 | $10 | $4 | $17 | $12 | $6 | $4 | ($2) | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $9 | $12 | $12 | $10 | $4 | $17 | $12 | $6 | $4 | ($2) | |
| Income (Loss) from Equity Method Investments | — | $321.0m | $289.0m | $225.0m | $256.0m | $461.0m | $5.0m | ($20.0m) | ($217.0m) | ($12.0m) | |
| Income (loss) from continuing operations | $3.8b | $4.9b | $4.7b | $3.4b | $1.4b | $5.6b | $3.9b | $2.1b | $1.4b | ($785.0m) | |
| Income (loss) from continuing operations before equity investments and income taxes | $4.9b | $5.2b | $5.0b | $3.8b | $1.1b | $6.3b | $4.8b | $2.6b | $1.8b | ($703.0m) | |
| Income (loss) from continuing operations before income taxes | $5.2b | $5.5b | $5.3b | $4.1b | $1.4b | $6.8b | $4.8b | $2.6b | $1.6b | ($715.0m) | |
| Income (loss) from discontinued operations, net of tax | ($10.0m) | ($18.0m) | ($8.0m) | ($7.0m) | ($2.0m) | ($6.0m) | ($5.0m) | ($5.0m) | $4.0m | $47.0m | |
| Interest income | $17.0m | $24.0m | $45.0m | $19.0m | $12.0m | $9.0m | $29.0m | $129.0m | $150.0m | $97.0m | |
| Investment Income, Interest | $17.0m | $24.0m | $45.0m | $19.0m | $12.0m | $9.0m | $29.0m | $129.0m | $150.0m | $97.0m | |
| Loss from equity investments | — | $321.0m | $289.0m | $225.0m | $256.0m | $461.0m | $5.0m | ($20.0m) | ($217.0m) | ($12.0m) | |
| Net (loss) income | $3.8b | $4.9b | $4.7b | $3.4b | $1.4b | $5.6b | $3.9b | $2.1b | $1.4b | ($738.0m) | |
| Other impairments | — | — | — | — | — | — | — | $255.0m | $949.0m | $279.0m | |
| Provision for income taxes | $1.4b | $598.0m | $613.0m | $648.0m | ($43.0m) | $1.2b | $882.0m | $501.0m | $240.0m | $70.0m | |
| Reclassification from AOCI, Current Period, before Tax, Attributable to Parent | — | ($308.0m) | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $5.2b | $5.5b | $5.3b | $4.1b | $1.4b | $6.8b | $4.8b | $2.6b | $1.6b | ($715.0m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $3.8b | $4.9b | $4.7b | $3.4b | $1.4b | $5.6b | $3.9b | $2.1b | $1.4b | ($785.0m) | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($10.0m) | ($18.0m) | ($8.0m) | ($7.0m) | ($2.0m) | ($6.0m) | ($5.0m) | ($5.0m) | $4.0m | $47.0m | |
| Net Income (Loss) Attributable to Parent | $3.8b | $4.9b | $4.7b | $3.4b | $1.4b | $5.6b | $3.9b | $2.1b | $1.4b | ($745.0m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | $3.8b | $4.9b | $4.7b | $3.4b | $1.4b | $5.6b | $3.9b | $2.1b | $1.4b | ($745.0m) | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.0m | ($2.0m) | $0 | $0 | — | — | — | — | — | — | |
| Common Stock, Dividends, Per Share, Declared | $3.33 | $3.55 | $4.00 | $4.15 | $4.20 | $4.44 | $4.70 | $4.94 | $5.27 | $5.45 | |
| Continuing operations (in dollars per share) | $9.15 | $12.28 | $12.03 | $9.60 | $4.25 | $16.77 | $11.83 | $6.48 | $4.14 | ($2.48) | |
| Discontinued operations (in dollars per share) | ($0.02) | ($0.05) | ($0.02) | ($0.02) | ($0.01) | ($0.02) | ($0.02) | ($0.02) | $0.01 | $0.14 | |
| Earnings Per Share, Basic | $9.15 | $12.23 | $12.04 | $9.59 | $4.24 | $16.77 | $11.84 | $6.48 | $4.16 | ($2.34) | |
| Earnings Per Share, Diluted | $9.13 | $12.23 | $12.01 | $9.58 | $4.24 | $16.75 | $11.81 | $6.46 | $4.15 | ($2.34) | |
| Costs and Expenses | $24.1b | $29.0b | $33.8b | $30.6b | $26.2b | $39.4b | $45.4b | $38.1b | $38.5b | $30.6b | |
| Current Income Tax Expense (Benefit) | $1.0b | $1.2b | $353.0m | $439.0m | ($374.0m) | $1.4b | $513.0m | $458.0m | $677.0m | $254.0m | |
| Interest Expense | $322.0m | $491.0m | $360.0m | $347.0m | $526.0m | $519.0m | $287.0m | $477.0m | ($481.0m) | ($487.0m) | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $481.0m | $487.0m | |
| Other Expenses | — | — | — | — | — | — | — | — | $1.7b | $1.6b | |
| Other Nonoperating Income (Expense) | $111.0m | $179.0m | $106.0m | $39.0m | $85.0m | $62.0m | ($72.0m) | ($58.0m) | $50.0m | $113.0m | |
| Other income (expense), net | $111.0m | $179.0m | $106.0m | $39.0m | $85.0m | $62.0m | ($72.0m) | ($58.0m) | $50.0m | $113.0m | |
| Research and Development Expense | $99.0m | $106.0m | $115.0m | $111.0m | $113.0m | $124.0m | $124.0m | $130.0m | $135.0m | $136.0m | |
| Research and development expenses | $99.0m | $106.0m | $115.0m | $111.0m | $113.0m | $124.0m | $124.0m | $130.0m | $135.0m | $136.0m | |
| Selling, General and Administrative Expense | $833.0m | $859.0m | $1.1b | $1.2b | $1.1b | $1.3b | $1.3b | $1.6b | $1.7b | $1.6b | |
| Selling, general and administrative expenses | $833.0m | $859.0m | $1.1b | $1.2b | $1.1b | $1.3b | $1.3b | $1.6b | $1.7b | $1.6b | |
| Income Tax Expense (Benefit) | $1.4b | $598.0m | $613.0m | $648.0m | ($43.0m) | $1.2b | $882.0m | $501.0m | $240.0m | $70.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.